Erik Agner Selected Research

PN 7051

1/2002

A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik Agner Research Topics

Disease

1	Premature Cardiac Complexes (Extrasystoles) 02/2003
1	Ventricular Tachycardia 02/2003
1	Thrombosis (Thrombus) 01/2002

Drug/Important Bio-Agent (IBA)

1	Factor VII (Proconvertin)IBA 01/2002
1	antithrombin III-protease complexIBA 01/2002
1	Cyclic PeptidesIBA 01/2002
1	Thromboplastin (Tissue Factor)IBA 01/2002
1	FibrinIBA 01/2002
1	PN 7051IBA 01/2002
1	Epidermal Growth Factor (EGF)IBA 01/2002

Therapy/Procedure

1	Therapeutics 02/2003